103 related articles for article (PubMed ID: 25721485)
1. Epothilone B induces human ovarian cancer OV-90 cell apoptosis via external pathway.
Rogalska A; Marczak A
Environ Toxicol Pharmacol; 2015 Mar; 39(2):700-12. PubMed ID: 25721485
[TBL] [Abstract][Full Text] [Related]
2. Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells.
Rogalska A; Gajek A; Marczak A
Toxicol In Vitro; 2014 Jun; 28(4):675-83. PubMed ID: 24583341
[TBL] [Abstract][Full Text] [Related]
3. Analysis of epothilone B-induced cell death in normal ovarian cells.
Rogalska A; Gajek A; Marczak A
Cell Biol Int; 2013 Dec; 37(12):1330-9. PubMed ID: 23955989
[TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
5. Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells.
Rogalska A; Gajek A; Marczak A
Phytomedicine; 2019 Aug; 61():152847. PubMed ID: 31029905
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells.
Griffin D; Wittmann S; Guo F; Nimmanapalli R; Bali P; Wang HG; Bhalla K
Gynecol Oncol; 2003 Apr; 89(1):37-47. PubMed ID: 12694652
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B.
Rogalska A; Marczak A; Gajek A; Szwed M; Śliwińska A; Drzewoski J; Jóźwiak Z
Toxicol In Vitro; 2013 Feb; 27(1):239-49. PubMed ID: 22995584
[TBL] [Abstract][Full Text] [Related]
8. Nuclear DNA Damage and Repair in Normal Ovarian Cells Caused by Epothilone B.
Rogalska A; Marczak A
Asian Pac J Cancer Prev; 2015; 16(15):6535-9. PubMed ID: 26434870
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer.
Khabele D; Lopez-Jones M; Yang W; Arango D; Gross SJ; Augenlicht LH; Goldberg GL
Gynecol Oncol; 2004 Apr; 93(1):19-26. PubMed ID: 15047209
[TBL] [Abstract][Full Text] [Related]
10. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
[TBL] [Abstract][Full Text] [Related]
12. Activation of apoptotic pathway in normal, cancer ovarian cells by epothilone B.
Rogalska A; Szula E; Gajek A; Marczak A; Jóźwiak Z
Environ Toxicol Pharmacol; 2013 Sep; 36(2):600-610. PubMed ID: 23838010
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
Runnebaum IB; Brüning A
Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
[TBL] [Abstract][Full Text] [Related]
14. Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells.
Yamaguchi H; Paranawithana SR; Lee MW; Huang Z; Bhalla KN; Wang HG
Cancer Res; 2002 Jan; 62(2):466-71. PubMed ID: 11809697
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
Huisman C; Ferreira CG; Bröker LE; Rodriguez JA; Smit EF; Postmus PE; Kruyt FA; Giaccone G
Clin Cancer Res; 2002 Feb; 8(2):596-606. PubMed ID: 11839682
[TBL] [Abstract][Full Text] [Related]
16. Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.
Bröker LE; Huisman C; Ferreira CG; Rodriguez JA; Kruyt FA; Giaccone G
Cancer Res; 2002 Jul; 62(14):4081-8. PubMed ID: 12124345
[TBL] [Abstract][Full Text] [Related]
17. Pro-apoptotic activity of new analog of anthracyclines--WP 631 in advanced ovarian cancer cell line.
Gajek A; Denel M; Bukowska B; Rogalska A; Marczak A
Toxicol In Vitro; 2014 Mar; 28(2):273-81. PubMed ID: 24287111
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.
Sun SY; Yue P; Zhou JY; Wang Y; Choi Kim HR; Lotan R; Wu GS
Biochem Biophys Res Commun; 2001 Jan; 280(3):788-97. PubMed ID: 11162590
[TBL] [Abstract][Full Text] [Related]
20. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
